Patents Assigned to Bioneer Corporation
-
Patent number: 8852920Abstract: The present invention relates to a micro-chamber plate and a manufacturing method of the same, more precisely a micro-chamber plate facilitating real-time measurement and analysis of fluorescence obtained from the reaction of multiple reaction solutions containing primers or probes selectively binding to each corresponding gene without cross-contamination in order to analyze biological samples containing numbers of genes and a manufacturing method of the same.Type: GrantFiled: September 22, 2008Date of Patent: October 7, 2014Assignee: Bioneer CorporationInventors: Han Oh Park, Gu-Young Song
-
Publication number: 20140291583Abstract: Provided are a method for manufacturing a carbon nanotube-metal oxide composite, and a carbon nanotube-metal oxide composite manufactured thereby, the method comprising: dispersing carbon nanotubes in a reductive solvent to prepare a dispersion liquid; adding a co-reducing agent and a metal precursor to the dispersion liquid to prepare a mixture liquid; and performing heat treatment on the mixture liquid to coat the metal precursor on the carbon nanotubes in a metal oxide form, so that there can be provided a carbon nanotube-metal oxide composite where metal oxide particles of several nm to several tens of nm are uniformly dispersed in carbon nanotubes or combined with surfaces of the carbon nanotubes in a coating type.Type: ApplicationFiled: September 26, 2012Publication date: October 2, 2014Applicant: BIONEER CORPORATIONInventors: Han Oh Park, Jae Ha Kim, Kuk Jin Yun
-
Publication number: 20140212919Abstract: Provided is a method of protein synthesis. The method of protein synthesis according to the present invention uses an automatic biological material purification apparatus including: a well plate kit; a heating part; and a magnetic field applying part, such that a plurality of target proteins may be more quickly and simply obtained as compared to target proteins obtained by using the existing method for expressing/purifying proteins through conventional cell culture, and a reproducible synthesis efficiency on the same proteins may be obtained due to no deviation between reaction wells.Type: ApplicationFiled: August 23, 2012Publication date: July 31, 2014Applicant: BIONEER CORPORATIONInventors: Han Oh Park, You Sang Cho, Jun Ho Jung, Ji Won Han, Nam Il Kim
-
Patent number: 8779114Abstract: Provided are an siRNA-polymer conjugate, and a method for preparing the same, and more specifically, to a hybrid conjugate formed by covalently bonding siRNA and a polymeric compound for improving the in vivo stability of siRNA, and to a preparation method of the hybrid conjugate. The conjugate of the present invention can improve the in vivo stability of siRNA, thereby achieving an efficient delivery of therapeutic siRNA into cells and exhibiting the activity of siRNA even with a small dose of a relative low concentration. Therefore, the conjugate can advantageously be used as not only an siRNA treatment tool for cancers and other infectious disease, but also a novel type siRNA delivery system.Type: GrantFiled: May 13, 2010Date of Patent: July 15, 2014Assignee: Bioneer CorporationInventors: Bo Ram Han, Han Oh Park, Mi Sik Shin, Sam Young Lee
-
Patent number: 8772472Abstract: Provided are an siRNA-polymer conjugate, and a method for preparing the same, and more specifically, to a hybrid conjugate formed by covalently bonding siRNA and a polymeric compound for improving the in vivo stability of siRNA, and to a preparation method of the hybrid conjugate. The conjugate of the present invention can improve the in vivo stability of siRNA, thereby achieving an efficient delivery of therapeutic siRNA into cells and exhibiting the activity of siRNA even with a small dose of a relative low concentration. Therefore, the conjugate can advantageously be used as not only an siRNA treatment tool for cancers and other infectious disease, but also a novel type siRNA delivery system.Type: GrantFiled: September 13, 2012Date of Patent: July 8, 2014Assignee: Bioneer CorporationInventors: Bo Ram Han, Han Oh Park, Mi Sik Shin, Sam Young Lee
-
Patent number: 8697020Abstract: The present invention relates to silica magnetic particles having a spherical form and a process for preparing the same. The silica magnetic particles prepared according to the present invention, which are silica particles that includes the magnetic particles and additionally have the functional group on the surfaces, has an advantage that the particle size distribution is uniform. Further, the silica magnetic particles prepared according to the present invention can be used as a reagent for separating biomaterials and a reagent for detecting biomaterials.Type: GrantFiled: February 13, 2009Date of Patent: April 15, 2014Assignee: Bioneer CorporationInventors: Jae-Ha Kim, Jong-Gwang Park, Jong-Hoon Kim, Han-Oh Park
-
Publication number: 20140087377Abstract: The present invention relates to a method of identifying nucleic acid-containing object, more precisely a method of identifying nucleic acid-containing object which comprises the following steps: (1) preparing nucleic acid-containing object having the nucleotide sequence complementary to the nucleotide sequence of RNA-dual probe; (2) reacting the nucleic acid included in the object with the buffer containing the RNA-dual probe conjugated with a reporter and a quencher respectively and RNase; and (3) detecting fluorescence generated from the reporter.Type: ApplicationFiled: March 13, 2012Publication date: March 27, 2014Applicant: BIONEER CORPORATIONInventors: Han Oh Park, Jung Young Choi, Eun Su Han, Gu Young Song, Won Seok Jang
-
Publication number: 20140060400Abstract: This invention relates to a device for effectively removing organic compounds from air by a carbon nanotube-catalyst composite having the two functions of an adsorption/catalytic incineration agent. The carbon nanotube-catalyst composite simultaneously adsorbs the organic compounds and completely decomposes them by a catalytic reaction, and the optimal reaction active temperature by catalytic incineration is low. The carbon nanotube-catalyst composite has a large surface area and has high adsorption performance and catalytic decomposition activity, and is thus applicable to filters that use the methods of adsorption and/or catalytic incineration. The device for removing organic compounds from air includes an adsorption/catalytic incineration reactor including the carbon nanotube-catalyst composite to remove organic compounds from air.Type: ApplicationFiled: November 24, 2011Publication date: March 6, 2014Applicant: BIONEER CORPORATIONInventors: Han Oh Park, Young-Mi Koo, Jae Ha Kim, Yang Won Lee
-
Publication number: 20140045244Abstract: The present invention relates to a reverse transcriptase having improved thermostability, more precisely a mutant reverse transcriptase with improved thermostability by substitution of one or more amino acids selected from the group consisting of the 63rd glutamine (Q63), the 264th lysine (K264), the 295th lysine (K295), the 306th threonine (T306), the 346th glutamic acid (E346), the 408th proline (P408), the 438th histidine (H438), and the 454th asparagin (N454) of the amino acid sequence of M-MLV originated reverse transcriptase represented by SEQ. ID. NO: 1 with other amino acids. The mutant reverse transcriptase of the present invention demonstrates excellent thermostability, compared with the wild type reverse transcriptase. Therefore, it is advantageous to obtain the target cDNA with stable reverse transcription activity even in the presence of RNA that can form the stable secondary structure at a high temperature.Type: ApplicationFiled: February 7, 2012Publication date: February 13, 2014Applicant: BIONEER CORPORATIONInventors: Han Oh Park, Sung Jun Yang, Sung Mo Joo, Byoung Oh Hwang
-
Patent number: 8551426Abstract: Provided are an RNase activity inhibitory compound to effectively control the activity of the RNase promoting degradation of extracted RNAs and, in addition, a sample storage container including the same. The RNase activity inhibitory compound and the sample storage container according to the present invention may be effectively used to store RNAs during RNA extraction or the extracted RNAs.Type: GrantFiled: June 12, 2009Date of Patent: October 8, 2013Assignee: Bioneer CorporationInventors: Jong Hoon Kim, Hwangseo Park, Han Oh Park
-
Publication number: 20130236903Abstract: Disclosed is an automatic nucleic acid purification apparatus which can prevent pollution due to aerosol generated from a biological sample containing high concentration target nucleic acid when the biological sample containing the high concentration target nucleic acid is mixed with other biological sample containing low concentration target nucleic acid or not containing the target nucleic acid. Further, disclosed is an automatic nucleic acid purification apparatus which can be applied to all kinds of nucleic acid purification equipments for purifying a plurality of biological samples using a magnet rode or a multi-pipette block moving in two or three axial directions, and which can minimize pollution due to the aerosol generated from the biological sample containing high concentration target nucleic acid and also can obtain accurate results.Type: ApplicationFiled: November 18, 2011Publication date: September 12, 2013Applicant: BIONEER CORPORATIONInventors: Han Oh Park, Byung Rae Jeong, Kwon Sic Kim
-
Patent number: 8530639Abstract: A method for isolating a nucleic acid from a biological sample includes applying particulate matter to promote co-aggregation and co-precipitation of insoluble aggregate by directly adding to the biological sample, adding to the biological sample in admixture with a cell lysis buffer, adding to the biological sample treated with a cell lysis buffer, adding to cell lysates in admixture with a buffer for forming denatured protein aggregate; or adding to cell lysates comprising the formed denatured protein aggregate. The particulate matter is selected from the group consisting of a material formed from an element of Ag, Fe, Ti, Al, Sn, Si, Cu, Mo, Ni, W or Zn, an oxide, a carbide, a nitride, a boride and a silicide thereof, and a mixture thereof, a polymer selected from PMMA (Poly Methyl MethAcrylate), polyethylene or polyurethane; and a mixture thereof. The insoluble aggregate comprises denatured protein aggregate and cell debris.Type: GrantFiled: December 11, 2007Date of Patent: September 10, 2013Assignee: Bioneer CorporationInventors: Jong-Hoon Kim, Min Kim, Hae-Joon Park, Han Oh Park
-
Publication number: 20130230860Abstract: The present invention relates to an automatic real-time quantitative amplification system which can perform analysis of various biological samples, and more particularly to an automatic real-time quantitative amplification system in which a plurality of decks for respectively accommodating biological samples are put in a deck storing/transferring device, whereby it is possible to automatically analyze an amount or existence of a target substance containing a target nucleic acid in the biologic sample, such as a particular gene, a particular, a particular pathogenic bacterium and a particular protein, by amplifying the target nucleic acid purified by some processes of purification, purification after culture, or purification after reaction of the target substance contained in the bio-logical sample and then checking an amount of the amplified target nucleic acid.Type: ApplicationFiled: October 27, 2011Publication date: September 5, 2013Applicant: BIONEER CORPORATIONInventors: Han Oh Park, Kwon Sic Kim, Yang Won Lee, Jin II Lee, Byung Rae Jeong, Jong Hoon Kim
-
Patent number: 8513399Abstract: The present invention relates to primers for PCR amplification comprising abasic parts within the primer sequences and a method for PCR amplification using the same. More precisely, the present invention relates to primers capable of amplifying different templates and having abasic parts complementary to mutated site or polymorphic site of template DNA and a method for PCR amplification comprising the steps of mixing the composition for PCR amplification comprising the primers with nucleic acid template; and performing PCR with the mixture. The primers for PCR amplification of the present invention contain abasic parts not having specific coding information in their nucleotide sequences, so that they can amplify different templates having mutated sites at the same time.Type: GrantFiled: October 2, 2008Date of Patent: August 20, 2013Assignee: Bioneer CorporationInventors: Hyun Bae Kim, Seong Youl Kim, Jun Mo Gil, Hae Joon Park, Han Oh Park
-
Publication number: 20130210133Abstract: Provided is a low heat capacity composite for a thermal cycler . The low heat capacity composite of the present invention is a low heat capacity composite for a thermal cycler capable of overcoming difficulty in manufacture and reproducibility due to uniqueness of the existing PCR thermal cycler only. The low heat capacity composite of the present invention can reduce the cost of raw material and retain excellent heat property due to the improvement in low heat capacity and physical and mechanical properties, thereby remarkably shortening PCR reaction time and saving energy when used as a thermal block for a thermal cycler.Type: ApplicationFiled: August 8, 2011Publication date: August 15, 2013Applicant: BIONEER CORPORATIONInventors: Han Oh Park, Jae Ha Kim
-
Publication number: 20130157275Abstract: Provided are an oligonucleotide marker and a method of identifying a material using the same. The oligonucleotide marker makes it possible to analyze a trace amount of the material with high precision within a short time, has improved solubility in an oily solvent, and can improve a detection method such that the oligonucleotide marker can be detected within 2 hours. The oligonucleotide marker can label various products, including oil products and petroleum products, works of art and collections, and can also be used to conduct criminal investigations.Type: ApplicationFiled: March 1, 2013Publication date: June 20, 2013Applicant: BIONEER CORPORATIONInventor: BIONEER CORPORATION
-
Publication number: 20130115686Abstract: The present invention relates to a micro chamber plate, and more particularly, to an analytic micro chamber plate in which a plurality of reaction solutions including a primer or probe selectively reacting with a nucleic acid react with each other without cross-contamination to measure and analyze a fluorescence level in real-time so as to analyze biological sample solution including a large amount of nucleic acids. Also, the present invention relates to a method of manufacturing the analytic chamber plate. Also, the present invention relates to a method of manufacturing a micro chamber plate with a built-in sample used for manufacturing the analytic chamber plate. Also, the present invention relates to an apparatus set for manufacturing the micro chamber plate with a built-in sample.Type: ApplicationFiled: June 1, 2011Publication date: May 9, 2013Applicant: Bioneer CorporationInventors: Han Oh Park, Gu Young Song, Jung A Bae
-
Patent number: 8427643Abstract: The present invention relates to a real-time PCR monitoring apparatus for real-time monitoring production of reaction product produced during the reaction while performing nucleic acid amplification such as PCR for various kinds of trace samples. Specifically, the present invention relates to an apparatus for real-time monitoring biochemical reaction for efficiently dividing interference between an excitation light and a fluorescence, which includes a polarizer, a polarizing beam splitter, a polarization converter and so on.Type: GrantFiled: June 17, 2008Date of Patent: April 23, 2013Assignee: Bioneer CorporationInventors: Hanee Park, Il kyu Choi, Han Oh Park
-
Publication number: 20130096288Abstract: Provided are an siRNA-polymer conjugate, and a method for preparing the same, and more specifically, to a hybrid conjugate formed by covalently bonding siRNA and a polymeric compound for improving the in vivo stability of siRNA, and to a preparation method of the hybrid conjugate. The conjugate of the present invention can improve the in vivo stability of siRNA, thereby achieving an efficient delivery of therapeutic siRNA into cells and exhibiting the activity of siRNA even with a small dose of a relative low concentration. Therefore, the conjugate can advantageously be used as not only an siRNA treatment tool for cancers and other infectious disease, but also a novel type siRNA delivery system.Type: ApplicationFiled: September 13, 2012Publication date: April 18, 2013Applicant: Bioneer CorporationInventors: Bo Ram Han, Han Oh Park, Mi Sik Shin, Sam Young Lee
-
Publication number: 20130043191Abstract: Disclosed is an automatic purification apparatus for isolating target substances from multiple biological samples, and more particularly to an automatic biological sample purification apparatus equipped with a magnetic field applying part, in which the magnetic field applying part for purifying biological samples and a heating part are integrally formed with each other so as to be movable up and down. Further, disclosed is a method of extracting a target substance from the biological sample using the automatic biological sample purification apparatus equipped with the magnetic field applying part.Type: ApplicationFiled: April 29, 2011Publication date: February 21, 2013Applicant: BIONEER CORPORATIONInventors: Han-oh Park, Jong-kab Kim, Yang-won Lee, Jong-hoon Kim